Clinical value of procalcitonin in critically ill patients infected by SARS-CoV-2
Background Blood procalcitonin (PCT) levels usually increase during infectious diseases and might be helpful to differentiate bacterial from non-bacterial origin. COVID-19 patients could present co-infections at initial presentation in the Emergency Department and nosocomial infections during stay in the ICU. However, the published literature has not established whether PCT changes could aid in the diagnosis of infectious complication during the COVID-19 pandemic. Methods Retrospective, single-center, cohort study, including COVID-19 patients admitted between March and May 2020.
Source: The American Journal of Emergency Medicine - Category: Emergency Medicine Authors: Pedro Garrido, Pitter Cueto, Conxita Rovira, Elisabeth Garcia, Ana Parra, Raquel Enriquez, Armando Pinos, Manuel Sosa, Anna Hern ández-Aguilera, Immaculada Vallverdú Source Type: research